PMGC HOLDINGS INC. Finance Lease, Liability, Undiscounted Excess Amount
PMGC HOLDINGS INC. (ELAB) had Finance Lease, Liability, Undiscounted Excess Amount of $44.37 thousand as of 2026-12-31, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-14
- 2026-12-31: Finance Lease, Liability, Undiscounted Excess Amount $44.37K.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-12-31 | $44.37K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |